Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 1.550
-0.100 (-6.06%)
Mar 24, 2026, 1:23 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 126.02 million as of March 24, 2026. Its market cap has increased by 283.70% in one year.
Market Cap
126.02M
Enterprise Value
126.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.55
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 126.02M, an increase of 1,243.05%. That is a compound annual growth rate of 8.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 126.02M | -30.38% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 201.53M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 67.67M |
| Sernova Biotherapeutics | 57.37M |
| NurExone Biologic | 55.19M |
| Medicenna Therapeutics | 54.22M |
| Defence Therapeutics | 43.84M |
| BriaCell Therapeutics | 42.49M |